Comparison Of Efficacy Of Tazarotene 0.045% Vs Halobetasol Propionate 0.01% Lotion For Treatment of Scalp Psoriasis
NCT06015152
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
90
Enrollment
OTHER_GOV
Sponsor class
Conditions
Scalp Psoriasis
Interventions
DRUG:
Tazarotene 0.045% Topical Application Lotion [ARAZLO]
Sponsor
Jinnah Postgraduate Medical Centre